You are using an older browser version. Please use a supported version for the best MSN experience.

CSL LIMITED

Germany: CSJ
126.48
+0.48
+0.38%
5/22/2019 7:59 PM CEST
5 Years
  • Open

    125.60

  • Previous Close

    126.00

  • Vol (3-Month Avg.)

    -

  • Day's Range

    125.60-126.48

  • 52 week range

    88.25-144.65

  • Yield

    0.86%

  • Category

    -

  • Lipper Risk

    -

Profile

Name of Issuer

-

Expenses

-

CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment manufactures, markets and develops plasma therapies (plasma products and recombinants). The Seqirus segment manufactures and distributes non-plasma biotherapeutic products. Seqirus manufactures, sells and distributes a range of vaccines, antivenoms and other pharmaceutical products in Australia and New Zealand. It also manufactures and markets in vitro diagnostic products through Seqirus immunohematology. The CSL Intellectual Property segment is engaged in licensing of intellectual property generated by the Company to unrelated third parties. The Company has facilities in Australia, Germany, Switzerland, the United Kingdom and the United States.

Inception

NA

AdChoices
image beaconimage beaconimage beacon